Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GRT6010 in Peripheral Neuropathic Pain
NCT01485094Phase 2Terminated
- Sponsor
- Grünenthal GmbH
- Start
- Feb 2012
- Primary completion
- Jan 2013
- Modality
- Small Molecules
- Countries
- 4
01
Overview
A Phase 2 trial of GRT6010 in Peripheral neuropathic pain, sponsored by Grünenthal GmbH. Started Feb 2012; status: terminated.
02
Drugs
GRT6010
03
Conditions
Peripheral neuropathic pain
Beyond the preview
Go deeper on NCT01485094.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01485094.